An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

In South Dallas, a local nonprofit is working to address disparities that affect life expectancy and heart disease outcomes ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Heart failure doesn’t always come with loud warnings. It is therefore important to listen to your body, recognise the silent ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a study published in ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...